A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue

Ping WuSection of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK

Brian A. WalkerSection of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK

Annemiek BroylDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Martin KaiserSection of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK

David C. JohnsonSection of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK

Rowan KuiperDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Mark van DuinDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Walter M. GregoryClinical Trials Research Unit, University of Leeds, Leeds, UK

Faith E. DaviesSection of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UK

Daniel BrewerProstate Cancer Genome Team, Institute of Cancer Research, Sutton, Surrey, UK

Dirk HoseMedizinische Klinik V, Universitaetsklinikum Heidelberg, Heidelberg, Germany

Pieter SonneveldDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands

Gareth J. MorganSection of Haemato-Oncology, Institute of Cancer Research, Sutton, Surrey, UKCorrespondence[email protected]

Your download is now in progress and you may close this window